Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.57 |
| ▸ | PPARG | P37231 | 7/20 | 0.57 |
| ▸ | PPARD | Q03181 | 7/20 | 0.57 |
| ▸ | PPARA | Q07869 | 7/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | FABP4 | P15090 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TLR2 | O60603 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.57 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.57 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1517158 | 1.00 | GPR84 (0.57) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL16062125 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL18263867 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL3693306 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL22833892 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL688904 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL297511 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL690625 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL159254 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL22711540 | 0.98 | GPR84 (0.59) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 296 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260090977-A1 | WATER-IN-OIL COSMETIC COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2026-04-02 | — | — | US | disclosed |
| EP-4688725-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | Wilmar International Limited (SG) | 2026-02-11 | — | — | EP | disclosed |
| US-20260035581-A1 | INK COMPOSITION FOR INKJET PRINTING | SAKATA INX CORP (JP) | 2026-02-05 | — | — | US | disclosed |
| EP-4686743-A1 | INK COMPOSITION FOR INKJET PRINTING | Sakata INX Corporation (JP) | 2026-02-04 | — | — | EP | disclosed |
| EP-3368592-B1 | COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN | DOW TORAY CO LTD (JP) | 2025-12-03 | — | — | EP | disclosed |
| WO-2025105449-A1 | OIL-IN-WATER TYPE EMULSION COSMETIC | 株式会社コーセー | 2025-05-22 | — | — | WO | disclosed |
| WO-2025028614-A1 | SOLID PARTICLE DISPERSION PREPARATION | ＮＯＶＩＧＯ Ｐｈａｒｍａ株式会社 | 2025-02-06 | — | — | WO | disclosed |
| WO-2024205503-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | WILMAR INTERNATIONAL LIMITED (SG) | 2024-10-03 | — | — | WO | disclosed |
| US-20240301207-A1 | AQUEOUS DISPERSION OF SILICONE RUBBER PARTICLES AND COSMETICS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-09-12 | — | — | US | disclosed |
| WO-2024171519-A1 | CHOLESTERIC LIQUID CRYSTAL COMPOSITION | 日本精化株式会社 | 2024-08-22 | — | — | WO | disclosed |
| US-20090186943-A1 | Antiseptic Ointment | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-23 | — | — | US | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| EP-2026746-A2 | SELF TANNING COMPOSITION | Ciba Holding Inc. (CH) | 2009-02-25 | — | — | EP | disclosed |
| WO-2009016064-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (CH) | 2009-02-05 | — | — | WO | disclosed |
| EP-1990050-A1 | DISINFECTANT OINTMENT | Maruishi Pharmaceutical Co., Ltd. (JP) | 2008-11-12 | — | — | EP | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| EP-1982697-A1 | EMULSION LOTION | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2008-10-22 | — | — | EP | disclosed |
| US-20080146678-A1 | O/W Emulsion Composition | TAISHO PHARMACEUTICAL., LTD. (JP) | 2008-06-19 | — | — | US | disclosed |
| WO-2007137958-A2 | SELF TANNING COMPOSITION | CIBA HOLDING INC. (CH) | 2007-12-06 | — | — | WO | disclosed |
| EP-1847243-A1 | O/W EMULSION COMPOSITION | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2007-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260090977-A1 | WATER-IN-OIL COSMETIC COMPOSITION | DEGS1, SQLE, FDFT1 | GPR84 1159/4885PPARG 130/4885PPARD 327/4885 |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | GPR84 3698/4885PPARG 449/4885PPARD 410/4885 |
| US-20240301207-A1 | AQUEOUS DISPERSION OF SILICONE RUBBER PARTICLES AND COSMETICS | SQLE, RER1, TMEM97 | GPR84 397/4885PPARG 1651/4885PPARD 1048/4885 |
| US-20260035581-A1 | INK COMPOSITION FOR INKJET PRINTING | CTNND1, FABP4, FZD7 | GPR84 3602/4885PPARG 95/4885PPARD 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.